Near Infrared Spectroscopy (NIRS) in Severe Sepsis (OTO-STS)
Primary Purpose
Critical Illness, Severe Sepsis
Status
Terminated
Phase
Phase 2
Locations
International
Study Type
Interventional
Intervention
Near Infrared Spectroscopy
conventional
Sponsored by
About this trial
This is an interventional treatment trial for Critical Illness focused on measuring near infrared spectroscopy, tissue oxygenation, organ dysfunction, mortality
Eligibility Criteria
Inclusion Criteria: Two of four criteria for the systemic inflammatory response syndrome; and one of the following: systolic blood pressure =< 90 mm Hg; or a blood lactate concentration => 4 mmol/l; or skin marbling; or impaired consciousness; or urine output < 30 ml/h. Exclusion Criteria: Age < 18 years Pregnancy Do-not-resuscitate status Advanced directives restricting implementation of the protocol Obesity (body mass index [BMI] > 30) Anasarca
Sites / Locations
- Raymond Poincaré Hospital
- Hôpital Nord AP HM
- CHU Tours
- GERLACH Herwig
- University Hospital Rostock
- NANAS Serafeim
- EZAVALA Elizabeth
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
1
2
Arm Description
Early goal directed therapy based on StO2 evaluation
Early goal directed therapy
Outcomes
Primary Outcome Measures
A combined endpoint of mortality and sequential organ failure assessment (SOFA) score increase at day 7 is the primary efficacy endpoint
Secondary Outcome Measures
duration of mechanical ventilation
length of the hospital stay
Full Information
NCT ID
NCT00167596
First Posted
September 9, 2005
Last Updated
July 19, 2016
Sponsor
University of Versailles
Collaborators
Hutchinson Technology Inc, Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT00167596
Brief Title
Near Infrared Spectroscopy (NIRS) in Severe Sepsis
Acronym
OTO-STS
Official Title
Phase III Study of Usefulness of Near Infrared Spectroscopy to Optimize Tissues Perfusion and Oxygenation in Severe Sepsis
Study Type
Interventional
2. Study Status
Record Verification Date
July 2016
Overall Recruitment Status
Terminated
Why Stopped
recruitment was stopped as consequence of cessation of funding (economic crisis)
Study Start Date
July 2005 (undefined)
Primary Completion Date
May 2009 (Actual)
Study Completion Date
December 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Versailles
Collaborators
Hutchinson Technology Inc, Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate the usefulness of an optimization of muscle perfusion and oxygenation, as assessed by the NIRS technique, in critically ill patients with sepsis.
Detailed Description
The systemic inflammatory response to sepsis may cause impaired tissue oxygenation that can persist despite the restoration of a normal hemodynamic profile and systemic oxygen transport.
Therefore, the assessment of tissue oxygenation and perfusion is recommended in patients with severe sepsis.
The InSpectra tissue spectrometer relies on continuous wave near infrared (NIR) technology to estimate non invasively local tissue hemoglobin oxygen saturation in tissue (% StO2). This technology had been tested in a variety of systems: standard theoretical models of light transport, isolated blood, isolated blood-perfused animal organs and healthy human volunteers with induced limb ischemia. In critical-care medicine, NIRS has also been used to evaluate muscle oxygenation in trauma resuscitation and in lower extremity and abdominal compartment syndrome. However, NIRS has been rarely utilised to measure tissue blood flow and oxygen uptake in critically ill patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness, Severe Sepsis
Keywords
near infrared spectroscopy, tissue oxygenation, organ dysfunction, mortality
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
103 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Early goal directed therapy based on StO2 evaluation
Arm Title
2
Arm Type
Active Comparator
Arm Description
Early goal directed therapy
Intervention Type
Device
Intervention Name(s)
Near Infrared Spectroscopy
Intervention Description
resuscitation will be based on Surviving Sepsis Campaign guidelines AND on increasing StO2 to 80% or more in at least 2 out of the 3 following sites: thenar, masseter and deltoid
Intervention Type
Device
Intervention Name(s)
conventional
Intervention Description
resuscitation will be based according to Surviving Sepsis Campaign
Primary Outcome Measure Information:
Title
A combined endpoint of mortality and sequential organ failure assessment (SOFA) score increase at day 7 is the primary efficacy endpoint
Time Frame
Day 7
Secondary Outcome Measure Information:
Title
duration of mechanical ventilation
Time Frame
from randomization to Day 28
Title
length of the hospital stay
Time Frame
from randomization to Day 90
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Two of four criteria for the systemic inflammatory response syndrome; and one of the following:
systolic blood pressure =< 90 mm Hg; or
a blood lactate concentration => 4 mmol/l; or
skin marbling; or
impaired consciousness; or
urine output < 30 ml/h.
Exclusion Criteria:
Age < 18 years
Pregnancy
Do-not-resuscitate status
Advanced directives restricting implementation of the protocol
Obesity (body mass index [BMI] > 30)
Anasarca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Djillali Annane, MD, PhD
Organizational Affiliation
Raymond Poincaré Hospital, AP-HP
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Olivier Nardi, MD
Organizational Affiliation
Raymond Poincaré Hospital, AP-HP
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Gwenhael Colin, MD
Organizational Affiliation
Raymond Poincaré Hospital, AP-HP
Official's Role
Principal Investigator
Facility Information:
Facility Name
Raymond Poincaré Hospital
City
Garches
ZIP/Postal Code
92380
Country
France
Facility Name
Hôpital Nord AP HM
City
Marseilles
ZIP/Postal Code
13
Country
France
Facility Name
CHU Tours
City
Tours
Country
France
Facility Name
GERLACH Herwig
City
Berlin
Country
Germany
Facility Name
University Hospital Rostock
City
Rostock
ZIP/Postal Code
18057
Country
Germany
Facility Name
NANAS Serafeim
City
Athens
Country
Greece
Facility Name
EZAVALA Elizabeth
City
Barcelona
Country
Spain
12. IPD Sharing Statement
Citations:
PubMed Identifier
29555789
Citation
Nardi O, Zavala E, Martin C, Nanas S, Scheeren T, Polito A, Borrat X, Annane D. Targeting skeletal muscle tissue oxygenation (StO2) in adults with severe sepsis and septic shock: a randomised controlled trial (OTO-StS Study). BMJ Open. 2018 Mar 19;8(3):e017581. doi: 10.1136/bmjopen-2017-017581.
Results Reference
derived
Learn more about this trial
Near Infrared Spectroscopy (NIRS) in Severe Sepsis
We'll reach out to this number within 24 hrs